---
title: "Vornado Realty Trust Stock 12‑Month Price Target Raised to $37, Implies 3% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292146138.md"
description: "Vornado Realty Trust's 12-month average price target was raised to $37 by 12 analysts, up from $36.31, with forecasts ranging from $28 to $45. Based on the July 8 closing price, this implies a 3% downside. The consensus rating remains 'Hold' among 13 covering analysts, comprising 4 Buys, 6 Holds, and 3 Sells."
datetime: "2026-07-09T04:20:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292146138.md)
  - [en](https://longbridge.com/en/news/292146138.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292146138.md)
generator: "portal-rs"
---

# Vornado Realty Trust Stock 12‑Month Price Target Raised to $37, Implies 3% Downside

-   According to estimates from 12 analysts, Vornado Realty Trust stock's average price target has risen from $36.31 to $37, with forecasts ranging from $28 to $45 per share
-   Based on the Jul. 8 closing price, the updated target implies approximately 3% potential downside
-   Consensus rating remains at “Hold” across 13 covering analysts, with 4 Buys, 6 Holds and 3 Sells

Explore more price target data and ratings for Vornado Realty Trust on the , and track all previous and future analyst recommendations for Vornado Realty Trust in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [VNO.US](https://longbridge.com/en/quote/VNO.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Vornado Realty Trust Q2 adjusted FFO per share rises on new rent commencements](https://longbridge.com/en/news/294738522.md)
- [CONMED (CNMD) Could Be 8% Overvalued Following Its Recent Rebound](https://longbridge.com/en/news/296318744.md)
- [Should FDA Clearance Of QIAstat-Dx Sepsis Panel Require Action From Qiagen (QGEN) Investors?](https://longbridge.com/en/news/296027748.md)
- [Is Apple Hospitality REIT (APLE) Still Cheap As Its Zacks Upgrade Draws Attention?](https://longbridge.com/en/news/296514330.md)
- [Arcus Biosciences (RCUS) Stock Looks Strong On Returns But Stretched On Sales](https://longbridge.com/en/news/296529363.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**